CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 443 filers reported holding CRISPR THERAPEUTICS AG in Q4 2021. The put-call ratio across all filers is 1.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $167,353 | -15.7% | 3,687 | +4.2% | 0.10% | -11.9% |
| Q2 2023 | $198,567 | +24.1% | 3,537 | 0.0% | 0.11% | +18.5% |
| Q1 2023 | $159,979 | +15.5% | 3,537 | +3.8% | 0.09% | +8.2% |
| Q4 2022 | $138,495 | -38.2% | 3,407 | -0.6% | 0.08% | -43.3% |
| Q3 2022 | $224,000 | +7.7% | 3,427 | 0.0% | 0.15% | +10.3% |
| Q2 2022 | $208,000 | -3.3% | 3,427 | 0.0% | 0.14% | +9.7% |
| Q1 2022 | $215,000 | +3.9% | 3,427 | +25.7% | 0.12% | +3.3% |
| Q4 2021 | $207,000 | -26.6% | 2,727 | +8.3% | 0.12% | -34.1% |
| Q3 2021 | $282,000 | +6.8% | 2,517 | +54.4% | 0.18% | -2.2% |
| Q2 2021 | $264,000 | +80.8% | 1,630 | +35.8% | 0.19% | +70.6% |
| Q1 2021 | $146,000 | – | 1,200 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $32,581,000 | 55.55% |
| NEA Management Company, LLC | 1,590,002 | $103,907,000 | 5.19% |
| ARK Investment Management | 8,237,122 | $538,296,000 | 3.75% |
| Nikko Asset Management Americas, Inc. | 4,262,736 | $277,078,000 | 3.54% |
| CLOUGH CAPITAL PARTNERS L P | 414,767 | $27,105,000 | 2.89% |
| Integral Health Asset Management, LLC | 220,000 | $14,377,000 | 2.79% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,268,000 | 2.48% |
| HC Advisors, LLC | 53,944 | $3,525,000 | 2.43% |
| Green Alpha Advisors, LLC | 27,466 | $1,795,000 | 1.52% |
| EFG Asset Management (North America) Corp. | 84,356 | $5,516,000 | 1.28% |